ursodeoxycholic acid has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, CG; Rubin, DT | 1 |
| Fujimura, T; Fushida, S; Harada, S; Hattori, T; Kinoshita, J; Miyashita, T; Mukaisho, K; Ohta, T; Ojima, E; Oyama, K; Tajima, H; Tsukada, T | 1 |
| Abdel-Latif, MM; Inoue, H; Reynolds, JV | 1 |
| Burnat, G; Konturek, PC; Majka, J | 1 |
| Almada, LL; Buttar, NS; Comba, A; Demars, CJ; Fernández-Zapico, ME; Gainullin, VG; Lomberk, G; Rizvi, S; Rizvi, Z; Wang, K | 1 |
| Fuke, H; Inoue, T; Ito, T; Miyashita, K; Nabeshima, K; Nakano, T; Shiraki, K; Sugimoto, K; Suzuki, M; Takase, K; Yamanaka, T | 1 |
| Ajani, J; Buttar, NS; Chen, CT; Chou, CK; Guha, S; Hsu, JM; Huang, P; Hung, MC; Izzo, JG; Kuo, HP; Lee, DF; Sun, HL; Wang, KK; Wei, Y; Wu, TT; Yen, CJ | 1 |
| Rhee, DK; Ryu, HC; Thao, TD; Yoo, SH | 1 |
| Handa, H; Hiramoto, M; Hirano, F; Makino, I; Makino, Y; Okamoto, K; Tanada, H | 1 |
| Barbara, L; Cicognani, C; Malavolti, M; Morselli-Labate, AM; Sama, C | 1 |
| Invernizzi, P; O'Connor, M; Salzman, AL; Setchell, KD; Szabó, C; Ueta, I | 1 |
| Calgaro, M; Fracchia, M; Galatola, G; Pellegrino, S; Pera, A; Secreto, P; Taraglio, S | 1 |
1 review(s) available for ursodeoxycholic acid and Adenocarcinoma
| Article | Year |
|---|---|
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
11 other study(ies) available for ursodeoxycholic acid and Adenocarcinoma
| Article | Year |
|---|---|
Chemoprevention of esophageal adenocarcinoma in a rat model by ursodeoxycholic acid.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; CDX2 Transcription Factor; Chemoprevention; Disease Models, Animal; Esophageal Neoplasms; Esophagus; Gene Expression Profiling; Histocytochemistry; Homeodomain Proteins; Immunohistochemistry; Male; Microscopy; NF-kappa B; Rats, Wistar; Transcription Factors; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
Topics: Adenocarcinoma; Apoptosis; Cell Proliferation; Cholagogues and Choleretics; Cyclooxygenase 2; Deoxycholic Acid; Esophageal Neoplasms; Humans; NF-kappa B; Signal Transduction; Tumor Cells, Cultured; Ursodeoxycholic Acid | 2016 |
Bile acids are multifunctional modulators of the Barrett's carcinogenesis.
Topics: Adenocarcinoma; Barrett Esophagus; CDX2 Transcription Factor; Cell Line, Tumor; Cyclooxygenase 2; Deoxycholic Acid; DNA Glycosylases; Down-Regulation; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Ursodeoxycholic Acid | 2010 |
Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Aspirin; Barrett Esophagus; Cell Growth Processes; Cyclin-Dependent Kinase 2; Disease Models, Animal; Down-Regulation; Esophageal Neoplasms; Humans; Oncogene Proteins; Promoter Regions, Genetic; Protein Binding; Rats; Trans-Activators; Transfection; Ursodeoxycholic Acid; Zinc Finger Protein GLI1 | 2010 |
Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Bile Acids and Salts; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Deoxycholic Acid; Dose-Response Relationship, Drug; Flow Cytometry; HT29 Cells; Humans; Time Factors; Ursodeoxycholic Acid | 2005 |
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Topics: Adenocarcinoma; Barrett Esophagus; Bile Acids and Salts; Cell Division; Chenodeoxycholic Acid; Esophageal Neoplasms; Gastroesophageal Reflux; Gene Expression Regulation, Neoplastic; Humans; Inflammation; NF-kappa B; Nitriles; Protein Kinases; RNA, Small Interfering; Sirolimus; Sulfones; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Ursodeoxycholic Acid | 2008 |
Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis.
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Apoptosis; Cell Line, Tumor; Dosage Forms; Free Radical Scavengers; Gastritis, Atrophic; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen Peroxide; Malate Dehydrogenase; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Neutrophils; Reactive Oxygen Species; RNA, Messenger; Stomach Neoplasms; Time Factors; Ursodeoxycholic Acid | 2008 |
Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids.
Topics: Activating Transcription Factor 1; Adenocarcinoma; Base Sequence; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acid; Cholic Acids; Colonic Neoplasms; Deoxycholic Acid; DNA Primers; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Activation; Gene Expression Regulation; Genetic Vectors; Humans; Lithocholic Acid; Molecular Sequence Data; NF-kappa B; Podophyllin; Podophyllotoxin; Protein Kinase C; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1996 |
Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Flutamide; Humans; Leuprolide; Male; Prostatic Neoplasms; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo.
Topics: Adenocarcinoma; Animals; Cell Line, Transformed; Cell Survival; Enzyme Induction; Enzyme Repression; Humans; Intestinal Mucosa; Intestinal Neoplasms; Kinetics; Lipopolysaccharides; Mitochondria; Molsidomine; Nitrates; Nitric Oxide Synthase; Nitrites; Oxygen Consumption; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1997 |
Biliary bile acid composition in gastric cancer.
Topics: Adenocarcinoma; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Deoxycholic Acid; Female; Humans; Male; Stomach Neoplasms; Ursodeoxycholic Acid | 1999 |